616 related articles for article (PubMed ID: 24099797)
1. Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.
Khalil RA
Biochem Pharmacol; 2013 Dec; 86(12):1627-42. PubMed ID: 24099797
[TBL] [Abstract][Full Text] [Related]
2. Vascular effects of estrogenic menopausal hormone therapy.
Reslan OM; Khalil RA
Rev Recent Clin Trials; 2012 Feb; 7(1):47-70. PubMed ID: 21864249
[TBL] [Abstract][Full Text] [Related]
3. Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.
Smiley DA; Khalil RA
Curr Med Chem; 2009; 16(15):1863-87. PubMed ID: 19442151
[TBL] [Abstract][Full Text] [Related]
4. Modulators of vascular sex hormone receptors and their effects in estrogen-deficiency states associated with menopause.
Serock MR; Wells AK; Khalil RA
Recent Pat Cardiovasc Drug Discov; 2008 Nov; 3(3):165-86. PubMed ID: 18991792
[TBL] [Abstract][Full Text] [Related]
5. Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease.
do Nascimento GR; Barros YV; Wells AK; Khalil RA
Curr Hypertens Rev; 2009 Nov; 5(4):283-306. PubMed ID: 20694192
[TBL] [Abstract][Full Text] [Related]
6. Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.
Masood DE; Roach EC; Beauregard KG; Khalil RA
Curr Drug Metab; 2010 Oct; 11(8):693-714. PubMed ID: 21189141
[TBL] [Abstract][Full Text] [Related]
7. Sex steroids and vascular responses in hypertension and aging.
Qiao X; McConnell KR; Khalil RA
Gend Med; 2008; 5 Suppl A():S46-64. PubMed ID: 18395683
[TBL] [Abstract][Full Text] [Related]
8. Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.
Khalil RA
Cardiovasc Hematol Agents Med Chem; 2010 Jan; 8(1):29-46. PubMed ID: 20210774
[TBL] [Abstract][Full Text] [Related]
9. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
Koledova VV; Khalil RA
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
[TBL] [Abstract][Full Text] [Related]
10. Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.
Ross RL; Serock MR; Khalil RA
Curr Cardiol Rev; 2008 Nov; 4(4):309-22. PubMed ID: 20066139
[TBL] [Abstract][Full Text] [Related]
11. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE-2017 UPDATE.
Cobin RH; Goodman NF;
Endocr Pract; 2017 Jul; 23(7):869-880. PubMed ID: 28703650
[TBL] [Abstract][Full Text] [Related]
12. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
13. Sex hormones, vascular function and the outcome of hormone replacement therapy in cardiovascular disease.
Khalil RA
Future Cardiol; 2007 May; 3(3):283-300. PubMed ID: 19804220
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor-mediated enhancement of venous relaxation in female rat: implications in sex-related differences in varicose veins.
Raffetto JD; Qiao X; Beauregard KG; Khalil RA
J Vasc Surg; 2010 Apr; 51(4):972-81. PubMed ID: 20347696
[TBL] [Abstract][Full Text] [Related]
15. Additive effects of low concentrations of estradiol-17β and progesterone on nitric oxide production by human vascular endothelial cells through shared signaling pathways.
Pang Y; Thomas P
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):258-267. PubMed ID: 27369115
[TBL] [Abstract][Full Text] [Related]
16. Differential vasoactive effects of oestrogen, oestrogen receptor agonists and selective oestrogen receptor modulators in rat middle cerebral artery.
Patkar S; Farr TD; Cooper E; Dowell FJ; Carswell HV
Neurosci Res; 2011 Sep; 71(1):78-84. PubMed ID: 21624404
[TBL] [Abstract][Full Text] [Related]
17. 27-Hydroxycholesterol, an Endogenous SERM, and Risk of Fracture in Postmenopausal Women: A Nested Case-Cohort Study in the Women's Health Initiative.
Chang PY; Feldman D; Stefanick ML; McDonnell DP; Thompson BM; McDonald JG; Lee JS
J Bone Miner Res; 2019 Jan; 34(1):59-66. PubMed ID: 30138538
[TBL] [Abstract][Full Text] [Related]
18. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.
Gleason CE; Dowling NM; Wharton W; Manson JE; Miller VM; Atwood CS; Brinton EA; Cedars MI; Lobo RA; Merriam GR; Neal-Perry G; Santoro NF; Taylor HS; Black DM; Budoff MJ; Hodis HN; Naftolin F; Harman SM; Asthana S
PLoS Med; 2015 Jun; 12(6):e1001833; discussion e1001833. PubMed ID: 26035291
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor subtypes mediate distinct microvascular dilation and reduction in [Ca2+]I in mesenteric microvessels of female rat.
Mazzuca MQ; Mata KM; Li W; Rangan SS; Khalil RA
J Pharmacol Exp Ther; 2015 Feb; 352(2):291-304. PubMed ID: 25472954
[TBL] [Abstract][Full Text] [Related]
20. Lessons from KEEPS: the Kronos Early Estrogen Prevention Study.
Miller VM; Taylor HS; Naftolin F; Manson JE; Gleason CE; Brinton EA; Kling JM; Cedars MI; Dowling NM; Kantarci K; Harman SM
Climacteric; 2021 Apr; 24(2):139-145. PubMed ID: 32880220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
